(571) 447-5500

Drug OTC GMPs and Labeling

Drug OTC GMPs and Labeling Seminar

A Five-Part Virtual Series

Presented by Lisa El-Shall, Victoria Pankovich, Jeb Hunter and Norma Skolnik

June 4, 11, 18, 24, and July TBD 2024

If you manufacture products in the OTC-drug space, including homeopathic, the challenges of FDA regulatory requirements become confusing. With a mixture of regulations spanning pharmaceutical Good Manufacturing Practices (GMPs) per 21 CFR Part 110 for pharmaceuticals, and proscriptive monographs categorized by therapeutic classes, covering labeling and claims, as well as registration and listing requirements under 21 CFR 207, these nonprescription products are held to intense scrutiny.

EAS’s five-part series on OTC GMPs and Labeling Compliance covers what you need to know to manufacture and market your products in accordance with FDA requirements. Covering inspection enforcement, labeling requirements, private label distributors, registrations and listings of your facilities and products as well as how to design an effective Adverse Events Reporting program, our team of experts will help you to understand what is required and how to comply.

June 4: OTC Labeling and Monographs

Presented by Norma Skolnik

June 11: Adverse Events Reporting

Presented by Victoria Pankovich and Lisa El-Shall

June 18: Private Label Distributor Requirements

Presented by Bruce Elsner

June 24: Compliance Inspection Enforcement

Presented by Lisa El-Shall

July TBD: Registration and Listing Requirements

Presented by Victoria Pankovich

Registration

Cost: $249
$199 for EAS, Certified Group and FSNS Clients

* discounts may apply

$199.00$249.00

Discounts

Two or more registrants from same company – 10% (use GROUP10 discount code at checkout)

Federal or state employees – 50% discount (use GOV50 discount code at checkout)

* only one discount code may be used

Cancellations

Cancellations will be refunded minus a $25 processing fee up to two weeks prior to the start date of the seminar. After this date, no refunds will be given.

Terms and Conditions
By submitting this form you will be joining the nearly 20,000 who receive the monthly EASeNews regulatory newsletter. Please note EAS never shares your information and you may unsubscribe at any time.

Posted in Drugs, Seminar.